ListarDepartamento de Ciencias Médicas y Quirúrgicas por tema "Liquid biopsy"
Mostrando ítems 1-4 de 4
-
Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer
(MDPI, 2020)Liquid biopsy may assist in the management of cancer patients, which can be particularly applicable in pancreatic ductal adenocarcinoma (PDAC). In this study, we investigated the utility of circulating cell-free DNA ... -
Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal
(MDPI, 2021)Hepatocellular carcinoma (HCC) is the fifth most common neoplasm and a major cause of cancer-related death worldwide. There is no ideal biomarker allowing early diagnosis of HCC and tumor surveillance in patients receiving ... -
Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
(MDPI, 2023)Circulating tumor cells (CTCs), and particularly circulating cancer stem cells (cCSC), are prognostic biomarkers for different malignancies and may be detected using liquid biopsies. The ex vivo culture of cCSCs would ... -
Personalized medicine in cancer: liquid biopsy-based biomarkers
(Universidad de Córdoba, UCOPress, 2021)Liquid biopsy is a non-invasive approach that provides tumour molecular profiling and may assist in the management of cancer patients. Therefore, here we investigated the utility of liquid biopsy-based biomarkers as ...